top of page

CONNECT seminar: The new EU regulations on IVDR – how to be prepared?

Updated: May 12, 2022

Here you will find two presentations held at a recent CONNECT meeting. The speakers explain how the new EU regulations on In Vitro Diagnostic Medical Devices (IVDR) work and what challenges the industry is facing with the new regulations.

The EU flag
EU regulations are changing. It affects large parts of the medical world. Illustration photo:

The seminar starts withs some hard facts. What is IVDR? What is the purpose of it, and why do we in Norway need to follow these regulations?

The first presentation is by Mohsen Shadidi from the Oslo University Hospital. He gives an introduction to EU In Vitro Diagnostics Regulations and status of the adaptation.

But what about the pharmaceutical industry? How are they affected by the new regulations? In the second presentation Tove Ofstad from Roche Diagnostics Norge AS discusses various drivers for the change and asks how the industry needs to adjust to meet the new requirements. What is challenging? What is the status now when there is less than one year left to implement?

We do what we can. Forget the Roche logo on the slide - the whole industry is doing what we can to reach our goal.

Tove Ofstad, Roche Diagnostics

About the speakers

Mohsen Shadidi, Head of section for Molecular Diagnostics, Department of Pathology, at Oslo University Hospital. Shadidi is a molecular biologist by education and has conducted cancer research both as a research fellow and postdoc.

Tove Ofstad, Market Access and Business Development Manager, Roche Diagnostics

Norge AS. Ofstad is a bioengineer who has worked in the primary health service in meetings with patients, has experience from laboratory work and further 28 years of experience from the health industry.

See the video of the presentations

You can access the video of the two presentations below. CONNECT partners can also access the slide decks via TEAM or reach out to Jutta Heix (

Subscribe newsletter and stay updated

Stay updated regarding news concerning IVDR by subscribing the newsletter from The Norwegian Medicines Agency (NOMA). You can also follow NOMA at Facebook.

Do you have any questions?

If you have any questions, please contact Jutta Heix (

We would like to say a big thank you to the speakers, stakeholders and all the participants at the seminar!

70 views0 comments

Recent Posts

See All


bottom of page